Centrifugation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Equipment, Accessories), By Model Type (Benchtop Centrifuges, Floor-Standing Centrifuges), By Application (Clinical Research, Biotherapeutic Manufacturing, Others), By End-User (Hospitals and Blood Banks, Biotechnology and Pharmaceutical Laboratories, Academic and Research Institutes, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 8.75 Billion
CAGR (2026-2031)	5.13%
Fastest Growing Segment	Equipment
Largest Market	North America
Market Size (2031)	USD 11.81 Billion

Market Overview

The Global Centrifugation Market will grow from USD 8.75 Billion in 2025 to USD 11.81 Billion by 2031 at a 5.13% CAGR. Centrifugation is a mechanical process utilizing centrifugal force to separate particles from a solution based on distinct physical properties such as density, viscosity, and size. The Global Centrifugation Market is primarily propelled by the expanding biopharmaceutical sector, specifically the intensifying demand for efficient separation technologies in drug discovery and vaccine production. This growth is further reinforced by the critical requirements of blood banks for component fractionation and the increasing application of these systems in clinical diagnostics. According to the 'International Federation of Pharmaceutical Manufacturers and Associations', in '2024', 'there were more than 12,700 medicines in various stages of development globally', a figure that underscores the robust research environment fueling the procurement of laboratory separation equipment.

However, a significant challenge potentially impeding market expansion is the substantial capital and maintenance expense associated with advanced centrifugation systems. The necessity for frequent rotor calibration, expensive component replacements, and specialized technical servicing imposes a heavy financial burden on smaller independent laboratories and healthcare facilities, particularly in cost-sensitive regions, which can limit the broader adoption of high-speed and ultracentrifuges.

Key Market Drivers

The rising prevalence of infectious and chronic diseases serves as a primary catalyst for the Global Centrifugation Market, necessitating advanced diagnostic and research capabilities. As the incidence of conditions such as cancer and blood disorders escalates, clinical laboratories and research institutions require high-performance centrifugation systems for the precise separation of biological samples, including blood components, DNA, and cellular materials, which are essential for accurate diagnosis and treatment planning. This increasing burden of disease directly correlates with the demand for reliable laboratory equipment to handle higher testing volumes. According to the American Cancer Society, January 2024, in the 'Cancer Facts & Figures 2024', it is projected that the number of new cancer diagnoses in the United States will exceed 2 million for the first time, highlighting the critical need for robust diagnostic infrastructure.

Simultaneously, the market is heavily influenced by the expansion of pharmaceutical and biotechnology research and development (R&D) activities aimed at discovering novel therapeutics and vaccines. Centrifuges are indispensable in these R&D workflows, utilized for cell harvesting, protein purification, and the isolation of active pharmaceutical ingredients. The intensifying focus on biologics and personalized medicine has led to a surge in investment toward laboratory technologies that ensure purity and yield. According to the European Federation of Pharmaceutical Industries and Associations, June 2024, in 'The Pharmaceutical Industry in Figures 2024', the research-based biopharmaceutical industry is estimated to have invested €50,000 million in R&D in Europe in 2023. Furthermore, government initiatives are fortifying this growth; according to the UK Government, in 2024, a £520 million commitment was announced for the Life Sciences Innovative Manufacturing Fund to secure major investments and support the production of life-saving medicines.

Download Free Sample Report

Key Market Challenges

The substantial capital and maintenance expenses associated with advanced centrifugation systems represent a significant barrier to the growth of the global market. High-performance centrifuges, particularly ultracentrifuges used in genomic and proteomic research, require a major upfront investment that strains the budgets of small-to-medium-sized laboratories and independent healthcare facilities. Beyond the initial purchase price, the total cost of ownership is elevated by the strict requirement for regular rotor calibration and specialized technical servicing to ensure safety and precision. These ongoing operational costs often force procurement departments to defer upgrading aging machinery, thereby slowing the replacement cycle necessary for market expansion.

Financial pressures on healthcare providers further exacerbate this issue, limiting the funds available for new capital equipment. According to the 'American Hospital Association', in '2025', '94% of health care administrators expect to delay equipment upgrades to manage financial strain'. This fiscal conservatism directly impacts the centrifugation market by reducing the adoption rate of newer technologies in cost-sensitive regions. Consequently, laboratories frequently opt to extend the lifespan of existing units rather than investing in modern systems, creating a measurable drag on overall industry revenue growth.

Key Market Trends

The increasing adoption of single-use centrifugation systems in biopharmaceutical manufacturing is fundamentally altering downstream processing workflows. As the demand for biologics and cell therapies intensifies, manufacturers are shifting away from traditional stainless-steel equipment to disposable technologies that eliminate cleaning validation steps and significantly reduce the risk of cross-contamination between batches. This transition enables faster changeovers and greater flexibility in multi-product facilities, directly addressing the industry's need for operational speed and sterility. According to Sartorius, February 2025, in the 'Annual Report 2024', the Bioprocess Solutions Division recorded a 12.7% increase in order intake in constant currencies, underscoring the recovering market demand for these advanced single-use manufacturing technologies.

Simultaneously, there is a decisive transition towards sustainable and energy-efficient laboratory equipment, driven by corporate net-zero pledges and rising operational costs. Laboratories are increasingly prioritizing centrifuges equipped with features such as hydrocarbon-based cooling, vacuum systems to reduce friction, and automatic standby modes to minimize electricity consumption during idle periods. This shift is supported by global initiatives that quantify and certify the environmental impact of research hardware, pushing manufacturers to innovate for lower carbon footprints. According to My Green Lab, January 2025, in 'A Year of Progress: My Green Lab’s Key Achievements in 2024', the International Laboratory Freezer Challenge resulted in participants saving 31.8 million kWh of energy, a metric that highlights the sector's broader commitment to reducing the energy intensity of essential devices including cold-storage and separation systems.

Segmental Insights

The equipment category is recognized as the fastest-growing segment in the global centrifugation market, driven largely by rising demand within the biopharmaceutical and clinical diagnostics industries. This expansion is fueled by the critical need for precise separation instruments in vaccine production, cell therapy, and drug discovery. Furthermore, strict adherence to manufacturing standards set by authorities like the U.S. Food and Drug Administration encourages facilities to upgrade their infrastructure regularly. This regulatory pressure combined with expanding research activities ensures a continuous investment in new centrifugation units to maintain compliance and operational reliability.

Regional Insights

North America leads the Global Centrifugation Market primarily due to a robust concentration of pharmaceutical and biotechnology enterprises that require extensive separation capabilities. The region benefits from substantial research and development investments which drive the consistent demand for laboratory equipment. Additionally, the presence of supportive regulatory frameworks from the U.S. Food and Drug Administration facilitates the approval and adoption of compliant medical devices. Continuous funding from institutions like the National Institutes of Health further sustains market growth by supporting academic and clinical research initiatives throughout the region.

Recent Developments

• In April 2025, Beckman Coulter Life Sciences launched the OptiMATE Gradient Maker, an automated instrument designed to streamline density gradient ultracentrifugation workflows. The new system addressed the time-consuming and manual nature of traditional gradient preparation by automating the mixing and dispensing steps, thereby reducing total purification time by up to 75%. It enabled laboratories to achieve more consistent and reproducible results in applications such as viral vector purification for gene therapy. The instrument featured a user-friendly interface and a compact benchtop design, allowing researchers to integrate advanced automation into their existing processes with minimal training and reduced risk of manual error.
• In March 2025, Thermo Fisher Scientific launched a new series of floor-model centrifuges, including the Cryofuge, BIOS, and LYNX lines, featuring the company's proprietary GreenCool technology. These systems were the first of their kind to utilize natural refrigerant cooling systems, ensuring compliance with evolving European Union and United States environmental regulations regarding fluorinated gases. The new models offered a Global Warming Potential of one, significantly reducing their environmental impact compared to traditional technologies. Additionally, the centrifuges were manufactured at a zero-waste facility powered by renewable energy, underscoring the company's commitment to sustainability in laboratory operations without compromising performance or sample safety.
• In July 2024, the Hettich Group entered into a strategic growth partnership with Bregal Unternehmerkapital to support its international expansion efforts. This collaboration aimed to strengthen the company's position in the global centrifugation market, with a particular focus on expanding its presence in Asia and the United States. The partnership provided Hettich with access to an extensive global network and expertise, facilitating both organic growth and potential future acquisitions. This move marked a significant step in the company's long-term strategy to enhance its development of innovative laboratory equipment and sustainable cooling solutions while remaining an independent family-owned business.
• In January 2024, GEA Group introduced "GEA X Control," a newly developed control system for its centrifuges designed to significantly enhance integration, connectivity, and data processing capabilities. This innovative system laid the architectural foundation for the future integration of artificial intelligence, which would enable faster data analysis and the self-optimization of centrifuge operations. The technology also offered improved connectivity with supervisory control and data acquisition systems, facilitating extended services such as the provision of customized software functions. Initially released for selected separator and decanter models in the dairy and renewables sectors, the company implemented a phased rollout to equip other machine types with the system throughout the year.

Key Market Players

• Agilent Technologies, Inc.
• QIAGEN N.V.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Eppendorf SE
• Corning Incorporated
• Hanil Scientific Inc.
• Daihan Scientific Co., Ltd.
• DLAB Scientific Co., Ltd.

By Product	By Model Type	By Application	By End-User	By Region
Equipment Accessories	Benchtop Centrifuges Floor-Standing Centrifuges	Clinical Research Biotherapeutic Manufacturing Others	Hospitals and Blood Banks Biotechnology and Pharmaceutical Laboratories Academic and Research Institutes Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Centrifugation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Centrifugation Market, By Product:

• Equipment
• Accessories

• Centrifugation Market, By Model Type:

• Benchtop Centrifuges
• Floor-Standing Centrifuges

• Centrifugation Market, By Application:

• Clinical Research
• Biotherapeutic Manufacturing
• Others

• Centrifugation Market, By End-User:

• Hospitals and Blood Banks
• Biotechnology and Pharmaceutical Laboratories
• Academic and Research Institutes
• Others

• Centrifugation Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE